Skip to main content
. 2021 Oct 4;22(2):200–209. doi: 10.1111/papr.13079

TABLE 1.

Patient demographic and clinical characteristics

Characteristic All patients (N = 288,715) Patients <65 years (n = 96,940) Patients ≥65 years (n = 191,775)
Age at index date (years), mean (SD) 67.7 (15.0) 50.5 (11.2) 76.3 (7.1)
Age categories (years), n (%)
18 to <30 5677 (2.0) 5677 (5.9) NA
30 to <40 12,182 (4.2) 12,182 (12.6) NA
40 to <50 20,689 (7.2) 20,689 (21.3) NA
50 to <60 31,574 (10.9) 31,574 (32.6) NA
60 to <70 65,653 (22.7) 26,818 (27.7) 38,835 (20.3)
70 to <80 89,860 (31.1) 0 (0.0) 89,860 (46.9)
≥80 63,080 (21.8) 0 (0.0) 63,080 (32.9)
Sex, male, n (%) 118,976 (41.2) 40,645 (41.9) 78,331 (40.8)
Follow‐up duration (days), median (IQR) 736.0 (329.0, 1295.0) 775.0 (341.0, 1364.0) 715.0 (323.0, 1262.0)
Follow‐up duration on treatment (days), median (IQR) 445.0 (161.0, 960.0) 458.0 (161.0, 1008.0) 439.0 (161.0, 939.0)
Diagnosis, n (%)
OA 68,556 (23.7) 19,171 (19.8) 49,385 (25.6)
CLBP 174,637 (60.5) 65,568 (67.6) 107,069 (55.8)
OA and CLBP 45,522 (15.8) 10,201 (10.5) 35321 (18.4)
Affected joints in OA patients, n (%)
Coxarthrosis 19,255 (6.7) 6,232 (6.4) 13,023 (6.8)
Gonarthrosis 94,823 (32.8) 23,140 (23.9) 71,683 (37.4)
Comorbidities, n (%)
Gastrointestinal disease 47,034 (16.3) 13,485 (13.9) 33,549 (17.5)
Renal disease 12,828 (4.4) 2701 (2.8) 10,127 (5.3)
Cardiovascular disease (excluding hypertension) 101,320 (35.1) 19,556 (20.2) 81,764 (42.6)
Hypertension 102,769 (35.6) 22,068 (22.8) 80,701 (42.1)
Diabetes mellitus 66,343 (23.0) 16,480 (17.0) 49,863 (26.0)
Health‐care facility setup
Public (government) 114,750 (39.7) 40,303 (41.6) 74,447 (38.8)
Public (local) 50,135 (17.4) 15,670 (16.2) 34,465 (18.0)
University 13,745 (4.8) 5847 (6.0) 7898 (4.1)
Private 110,085 (38.1) 35,120 (36.2) 74,965 (39.1)

Abbreviations: CLBP, chronic low back pain; IQR, interquartile range; OA, osteoarthritis.